West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
219.46
+6.40 (3.00%)
At close: May 12, 2025, 4:00 PM
219.46
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
WST Market Cap
WST has a market cap or net worth of $15.77 billion as of May 12, 2025. Its market cap has decreased by -44.23% in one year.
Market Cap
15.77B
Enterprise Value
15.67B
1-Year Change
-44.23%
Ranking
Category
Stock Price
$219.46
Market Cap Chart
Since December 1, 1998, WST's market cap has increased from $506.90M to $15.77B, an increase of 3,010.51%. That is a compound annual growth rate of 13.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 15.31B | -35.47% |
Dec 31, 2024 | 23.72B | -8.95% |
Dec 29, 2023 | 26.05B | 49.53% |
Dec 30, 2022 | 17.42B | -49.85% |
Dec 31, 2021 | 34.74B | 65.89% |
Dec 31, 2020 | 20.94B | 88.30% |
Dec 31, 2019 | 11.12B | 53.17% |
Dec 31, 2018 | 7.26B | -0.88% |
Dec 29, 2017 | 7.33B | 18.01% |
Dec 30, 2016 | 6.21B | 43.01% |
Dec 31, 2015 | 4.34B | 14.73% |
Dec 31, 2014 | 3.78B | 10.44% |
Dec 31, 2013 | 3.43B | 83.39% |
Dec 31, 2012 | 1.87B | 46.01% |
Dec 30, 2011 | 1.28B | -6.74% |
Dec 31, 2010 | 1.37B | 6.05% |
Dec 31, 2009 | 1.29B | 4.69% |
Dec 31, 2008 | 1.24B | -5.93% |
Dec 31, 2007 | 1.31B | -21.48% |
Dec 29, 2006 | 1.67B | 110.73% |
Dec 30, 2005 | 793.90M | 3.62% |
Dec 31, 2004 | 766.20M | 55.23% |
Dec 31, 2003 | 493.60M | 39.87% |
Dec 31, 2002 | 352.90M | -7.52% |
Dec 31, 2001 | 381.60M | 8.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |